Abstract
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Introduction
The levansucrase inactivation construct (LevFragA-ERM-LevFragB) was ligated into 166 pGEM®7Zf(+), a high copy number plasmid in E. coli JM109, which behaves as a non-replicative LevFragA-ERM-LevFragB (recombinant pGEM®7Zf(+)) was purified using GenCatch advanced
191
PCR extraction kit (Epoch Life Science, Sugar Land, TX).
192
Transformation of competent E. coli JM 109 193 The recombinant pGEM®7Zf(+) was used to transform competent E. coli JM 109 cells. The Colonies with the correct insert were grown in LB medium supplemented with 50 µg/ml ampicillin 203 and the recombinant plasmid was isolated and purified using GenCatch plus plasmid DNA miniprep 204 kit (Epoch Life Science, Sugar Land, TX) and stored at -20 °C prior to use.
205
Electro-transformation of competent P. polymyxa protoplasts 206 Following initial unsuccessful attempts to transform competent P. polymyxa cells with the 207 recombinant pGEM®7Zf(+) harboring the levansucrase inactivation construct via electroporation, 208 competent P. polymyxa protoplasts were generated and used instead. Indeed, the cell wall of P. polymyxa was removed by a previously described method (25) with slight modifications. Briefly, P.
210
polymyxa cells were grown in tryptic soy broth (TSB) for 12 h until cell optical density (OD 600nm ) 211 reached 0.7. The cells were harvested and placed in 50 ml centrifuge tubes pre-chilled on ice for 20 min and then washed twice with 50 mM Tris-Maleate buffer (pH 7.1) containing 2 mM 213 dithiothreitol followed by centrifugation at 1000 x g and 4°C for 7 min. The cell pellets were 214 harvested and re-suspended in Tris-Maleate buffer (pH 7.1) containing 0.6 M sucrose, 5 mM MgCl 2 215 and 300 µg/ml lysozyme (Amresco®, Solon, OH). The cell suspension was incubated in an
216
ISOTEMP 220 water bath (Fischer Scientific, Pittsburg, PA) for 60 min at 37°C to make P.
217
polymyxa protoplasts. P. polymyxa protoplasts were harvested by centrifugation at 1000 x g and 4°C 218 for 7 min. P. polymyxa protoplasts were made competent by washing the protoplasts twice with 219 10% polyethylene glycol (PEG-8000) and re-suspended in 500 µl of 10% PEG-8000. The protoplasts in a pre-chilled 0.2 cm electroporation cuvette and then placed on ice for 5 min.
224
Electroporation was performed at 2.5 kV, 25 µF capacitance and infinite resistance as previously 225 described (26) in a Bio-Rad Gene Pulser Xcell™ electroporator (Bio-Rad, Hercules, CA). Electric 226 pulse was delivered to the protoplasts between 2.5 and 4.1 milliseconds. Following electroporation, 227 the protoplasts were placed on ice for 5 min and then 500 µl of TSB was added and the mixture was 228 incubated at 35 °C for 6 h to allow protoplast recovery. The recovered cells were plated on tryptic 229 soy agar (TSA) supplemented with 35 µg/ml erythromycin and incubated at 35°C for 16 -24 h.
230
Colonies were selected and mixed with 50 µl of TSB and then re-plated on a fresh TSA plate 231 supplemented with 35 µg/ml erythromycin and incubated at 35°C for 12 h. Fresh colonies were then 232 selected and colony PCR technique was used to screen for the presence of erythromycin gene. The 233 colonies with erythromycin gene were transferred to TSB supplemented with 50 µg/ml 234 erythromycin. The cells were harvested and genomic DNA was extracted as described above. PCR 235 was performed to screen for the presence of LevFragA-ERM, ERM and ERM-LevFragB fragments using genomic DNA as template. The presence of all three fragments confirmed that levansucrase 237 gene was successfully inactivated via double-cross homologous recombination.
238
Characterization of P. polymyxa levansucrase null mutant 239 The P. polymyxa levansucrase null mutant was characterized for cell growth, EPS and 2,3-240 BD production. Batch fermentations were conducted in sucrose-and glucose-based media. One 241 milliliter of 50% glycerol stock of P. polymyxa levansucrase null mutant was inoculated into 30 ml Corporation, Milford, MA) maintained at a flow rate of 0.6 ml/min as described previously (29).
292
The EPS produced during fermentation was quantified using a method described by (30)
293
with modifications. Culture broth was centrifuged at 8,000 x g for 10 min to pellet the cells while and 2.5 ml concentrated sulfuric acid (Fischer Scientific, Pittsburg, PA) was added to the mixture.
302
The mixture was left to stand for 10 min. The text tubes containing the mixture were incubated at 303 25°C for 10 min. After incubation, the mixture was gently vortexed and absorbance was measured [EPS] A . The EPS produced during levansucrase activity was determined from the equation below:
Where [EPS] L represents the concentration of EPS synthesized during levansucrase assay.
322
The concentrations of protein in the supernatants were determined by Bradford method (34).
323
One unit of levansucrase activity was defined as the milligram of protein that catalyzed the 324 formation of one μmoles of EPS (levan) per min at 35°C in 1 M sucrose solution.
325
Growth rate and generation time of levansucrase null mutant
326
To determine the stability of the levansucrase null mutant, the growth curve was first 327 obtained. Cells were grown to exponential phase (10 h) in the pre-culture medium (7), then 328 harvested and washed twice with sterile distilled water by centrifugation at 5,000 x g for 3 min. The ERM-LevFragB genes corresponding to 1008, 800, and 1015 bp, respectively (Fig 2) , thus 395 confirming successful double-cross homologous recombination. (Table 4) .
434
With glucose, addition of 0.2 and 0.4 g/L CaCl 2 to cultures of the levansucrase null mutant 435 increased growth by 27% and 34%, respectively, compared to the null mutant grown in cultures
436
without CaCl 2 supplementation (Table 5) . Similarly, the wildtype exhibited 25% and 17% increased CaCl 2 supplementation), respectively. However, the 2,3-BD yield and productivity of the 447 levansucrase null mutant in glucose cultures increased by 3% and 4% (without CaCl 2 ), and 2% and 448 128%, respectively, in the CaCl 2-supplemented cultures, respectively, relative to the wildtype ( Table 5 ). The observed increased glucose utilization rate of the levansucrase null mutant may be 450 responsible for the enhanced 2,3-BD titer, yield and productivity relative to the wildtype.
451
The levansucrase null mutant efficiently converted sucrose to 2,3-BD with diminished 452 ability to produce EPS (Fig. 2B) were detected in the wildtype cultures grown on glucose without any measurable levansucrase 534 activity (Fig. 6) . indicates that other genes may be involved in the biosynthesis of other forms of EPS by P.
559 polymyxa (Fig 7) . Hence, physicochemical characterization of the EPS obtained in glucose cultures
560
of P. polymyxa may shed more light on the other EPS forms.
561
Whereas EPS production was significantly reduced in the levansucrase mutant when 562 compared to the wildtype, this did not translate to significant increase in 2,3-BD production with 563 sucrose as substrate. In parallel, while sucrose utilization by the levansucrase null mutant was 1.3-
564
fold lower than that of the wildtype, the amount of 2,3-BD produced was similar for both strains ( highlights ethanol biosynthesis as a veritable candidate for future inactivation towards developing a 585 2,3-BD over-producing strain.
586
Levansucrase inactivation in P. polymyxa interferes with acetic acid re-assimilation
587
The P. polymyxa levansucrase null mutant was characterized for growth by measuring (Fig. 3E) . To mitigate pH-related stresses and increase growth and 592 product formation, CaCl 2 was added to P. polymyxa levansucrase null mutant and wildtype cultures.
593
CaCl 2 supplementation enhanced the growth, 2,3-BD production, sugar utilization, and tolerance to 594 pH stresses in P. polymyxa, particularly, the levansucrase null mutant (Figs. 3 -5 
